Operational Efficiency in the Cardiac Cath Lab: The Time for Metrics Is at Hand
Review paper lays out a blueprint and call to action
Related Articles
Revising the US Lung Allocation System to Improve Patient Access to Transplant
Following the implementation of a new lung allocation system, Cleveland Clinic pulmonologists are working on further lowering waitlist times and patient mortality.
Obesity & risk of GVHD
Study examines the risk of obesity in patients undergoing allogeneic hematopoietic cell transplant
Researchers Identify Potential Risk Genes and Drug Repurposing Candidates in Parkinson’s Disease
Our researchers have successfully applied advanced AI genetics models to identify potential risk genes for Parkinson’s disease and drugs that may be repurposed for its…
IVIG Therapy Shows Promise in Reducing Symptom Severity for AGID
New research indicates that intravenous immunoglobulin (IVIG) therapy can reduce symptom severity for patients with gastroparesis.
Hoarseness: When to Observe and When to Refer
Cleveland Clinic physicians review laryngeal anatomy and function, causes of dysphonia and current AAO-HNS guidelines on diagnosis and treatment of hoarseness.
Teamwork and Quick Action Help 4-Year-Old with Mysterious Nasal Symptoms
When a pediatric patient presented with severe congestion, snoring and a progressive cough, X-ray findings revealed the surprising source of the patient’s symptoms.
Imaging Options Compared for Septal and Mitral Measurement in Myectomy for HOCM
New prospective data could shape how multimodality imaging is used in surgical planning for patients with hypertrophic obstructive cardiomyopathy. New research on optimal imaging modalities…
CSF Alpha-Synuclein Biomarker Strongly Associated With Clinical Features of Dementia With Lewy Bodies
A positive result on an alpha-synuclein assay is highly associated with clinical features of dementia with Lewy bodies, especially a reduced sense of smell. Multicenter…
Co-Testing in the ED to Slow the Spread of HIV
Patients being seen in the ED for common sexually transmitted infections should be screened for HIV, too.
New Targeted Therapy for GE Cancer
A newly approved targeted therapy, zolbetuximab, improves outcomes for patients whose tumor express the protein CLDN18.2.